Page last updated: 2024-10-30

mechlorethamine and Anti-Glomerular Basement Membrane Disease

mechlorethamine has been researched along with Anti-Glomerular Basement Membrane Disease in 1 studies

nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.

Anti-Glomerular Basement Membrane Disease: An autoimmune disease of the KIDNEY and the LUNG. It is characterized by the presence of circulating autoantibodies targeting the epitopes in the non-collagenous domains of COLLAGEN TYPE IV in the basement membranes of kidney glomeruli (KIDNEY GLOMERULUS) and lung alveoli (PULMONARY ALVEOLI), and the subsequent destruction of these basement membranes. Clinical features include pulmonary alveolar hemorrhage and glomerulonephritis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cameron, JS1

Reviews

1 review available for mechlorethamine and Anti-Glomerular Basement Membrane Disease

ArticleYear
Immunosuppressant agents in the treatment of glomerulonephritis. 2. Cytotoxic drugs.
    Journal of the Royal College of Physicians of London, 1971, Volume: 5, Issue:4

    Topics: Adult; Anti-Glomerular Basement Membrane Disease; Antilymphocyte Serum; Antineoplastic Agents; Azath

1971